Public Investment Fund’s Pfizer PFE Stock Holding History

Public Investment Fund’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,739,600	Closed	-$46.2M	–	73
2024 Q4	$46.2M	Buy	+1,739,600	New	+$47.2M	0.17%	38

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

TIM

Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Public Investment Fund's PFE Position: Q2 2020 in Review

Public Investment Fund sold out of Pfizer (PFE) in Q2 2020, closing a stake of 2,535,666 shares — an estimated $78.5M sold.

Public Investment Fund first reported a position in PFE in Q1 2020 and held it in 1 quarter. The position peaked at $78.5M in Q1 2020. 2,442 funds tracked by Wall St. Rank hold PFE as of Q2 2020.

Public Investment Fund reported no remaining Pfizer position as of Q2 2020 after selling out during the quarter.
Public Investment Fund sold 2,535,666 Pfizer shares in Q2 2020, an estimated $78.5M.
Public Investment Fund first reported a position in Pfizer in Q1 2020 and held it in 1 quarter.
Public Investment Fund's Pfizer position peaked at $78.5M in Q1 2020.
2,442 funds tracked by Wall St. Rank held Pfizer as of Q2 2020.

Based on Public Investment Fund's 13F filing for Q2 2020, filed 14 Aug 2020.